科罗拉多早产儿视网膜病变筛查模型的验证
该研究基于G-ROP研究数据,验证科罗拉多早产儿视网膜病变(CO-ROP)模型在大型多中心队列中的表现。CO-ROP模型对严重ROP的敏感性为96.9%,特异性为40.9%,漏诊23例(3.1%)严重ROP患儿,可使接受检查的婴儿数减少26.1%。结论认为该模型敏感性高但非100%,在考虑临床实施前需要修订。
要点
- CO-ROP模型对严重ROP的敏感性为96.9%,特异性为40.9%。
- 模型漏诊23例(3.1%)严重ROP患儿。
- 模型可使接受检查的婴儿数减少26.1%。
核心结论
- CO-ROP模型在此大型验证队列中显示出高但非100%的敏感性,漏诊了可能需要治疗的患儿。
- 模型需要满足全部3项标准才提示需要检查,但一些出生体重或胎龄高于阈值的婴儿仍发展为严重ROP。
- 这些未被CO-ROP模型检测到的婴儿大多存在明显的预期体重轨迹偏离或非生理性体重增长。
- 这些发现表明,CO-ROP模型在考虑实施于临床实践之前需要修订。
研究设计与样本
- 本研究是对出生后生长与早产儿视网膜病变(G-ROP)研究数据的二次分析,该研究为回顾性多中心队列研究,于2006年1月至2012年6月在美国和加拿大的29家医院开展,纳入6351名接受ROP检查的早产儿。
主要发现
- 在7438名G-ROP研究婴儿中,3575名(48.1%)为女孩;母亲种族/族裔为:非裔美国人2310名(31.1%)、白人3615名(48.6%)、亚裔233名(3.1%)、美洲印第安人/阿拉斯加原住民40名(0.52%)、太平洋岛民93名(1.3%)。
- 在研究队列中,747名婴儿(11.8%)患有1型或2型ROP,2068名(32.6%)患有较低级别ROP,3536名(55.6%)无ROP。
- CO-ROP模型的敏感性为96.9%(95%CI,95.4%-97.9%),特异性为40.9%(95%CI,39.3%-42.5%)。
- 模型漏诊了23名(3.1%)发展为严重ROP的婴儿。
- CO-ROP模型可使接受检查的婴儿数减少26.1%(95%CI,25.0%-27.2%)。
关键数值与推荐
- CO-ROP模型应用于G-ROP数据集中具有全部3个数据点的婴儿,满足全部3项标准(出生体重<1501 g、胎龄<30周、WG-28<650 g)的婴儿将接受检查。
- 缺失WG-28信息的婴儿纳入二次分析,其中WG-28被视为小于650 g。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The Colorado Retinopathy of Prematurity (CO-ROP) model uses birth weight, gestational age, and weight gain at the first month of life (WG-28) to predict risk of severe retinopathy of prematurity (ROP). In previous validation studies, the model performed very well, predicting virtually all cases of severe ROP and potentially reducing the number of infants who need ROP examinations, warranting validation in a larger, more diverse population. OBJECTIVE: To validate the performance of the CO-ROP model in a large multicenter cohort. DESIGN, SETTING, PARTICIPANTS: This study is a secondary analysis of data from the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study, a retrospective multicenter cohort study conducted in 29 hospitals in the United States and Canada between January 2006 and June 2012 of 6351 premature infants who received ROP examinations. MAIN OUTCOMES AND MEASURES: Sensitivity and specificity for severe (early treatment of ROP [ETROP] type 1 or 2) ROP, and reduction in infants receiving examinations. The CO-ROP model was applied to the infants in the G-ROP data set with all 3 data points (infants would have received examinations if they met all 3 criteria: birth weight, <1501 g; gestational age, <30 weeks; and WG-28, <650 g). Infants missing WG-28 information were included in a secondary analysis in which WG-28 was considered fewer than 650 g. RESULTS: Of 7438 infants in the G-ROP study, 3575 (48.1%) were girls, and maternal race/ethnicity was 2310 (31.1%) African American, 3615 (48.6%) white, 233 (3.1%) Asian, 40 (0.52%) American Indian/Alaskan Native, and 93 (1.3%) Pacific Islander. In the study cohort, 747 infants (11.8%) had type 1 or 2 ROP, 2068 (32.6%) had lower-grade ROP, and 3536 (55.6%) had no ROP. The CO-ROP model had a sensitivity of 96.9% (95% CI, 95.4%-97.9%) and a specificity of 40.9% (95% CI, 39.3%-42.5%). It missed 23 (3.1%) infants who developed severe ROP. The CO-ROP model would have reduced the number of infants who received examinations by 26.1% (95% CI, 25.0%-27.2%). CONCLUSIONS AND RELEVANCE: The CO-ROP model demonstrated high but not 100% sensitivity for severe ROP and missed infants who might require treatment in this large validation cohort. The model requires all 3 criteria to be met to signal a need for examinations, but some infants with a birth weight or gestational age above the thresholds developed severe ROP. Most of these infants who were not detected by the CO-ROP model had obvious deviation in expected weight trajectories or nonphysiologic weight gain. These findings suggest that the CO-ROP model needs to be revised before considering implementation into clinical practice.
引用
- McCourt EA, Ying GS, Lynch AM, et al. Validation of the Colorado Retinopathy of Prematurity Screening Model. JAMA Ophthalmol. 2018. PMID: 29543944. doi:10.1001/jamaophthalmol.2018.0376
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。